Pedro Claus Juan Moller-San, Chief Executive Officer at Y-mAbs Therapeutics, Inc. (YMAB), bought 1,900 shares at $17.22 ($33K) on 2020-03-17, disclosed to the SEC on 2020-03-19.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |